The global infectious disease diagnostics
market size is projected to reach USD 39.8 billion by 2026 from USD 28.1
billion in 2021, at a CAGR of 7.2% during the forecast period. Growth in the
infectious disease diagnostics industry is mainly driven by factors such as the
rising prevalence of infectious diseases & onset of COVID-19 and the rising
funding for R&D in infectious disease diagnostics. The growing awareness
for early disease diagnosis, shift in focus from centralized laboratories to
decentralized point-of-care testing and rising technological advancements are
factors supporting the growth of this market. On the other hand, an unfavorable
reimbursement scenario is expected to limit market growth to a certain extent in
the coming years. Growth opportunities in growing economies provide lucrative
opportunities for the players operating in the infectious disease diagnostics
market.
Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589
The reagents, kits, and consumables
segment accounted for the largest share of the infectious disease diagnostics
market, by product & service segment, in 2020
Based on product & service, the
infectious disease diagnostics market is segmented into reagents, kits, and
consumables; instruments; and software & services. In 2020, the reagents,
kits, and consumables segment accounted for the largest share of this market.
The frequent purchase of these products due to their recurrent usage drives the
market growth of this segment.
POC testing segment to register the
highest CAGR during the forecast period
Based on the type of testing, the
infectious disease diagnostics market has been segmented into laboratory
testing and POC testing. In 2020, the POC testing segment accounted for the
highest CAGR. This can be attributed to the need to closely monitor patient
conditions and advantages such as faster diagnosis.
The COVID-19 segment accounted for the
largest share of the infectious disease diagnostics market, by disease type
segment, in 2020
Based on disease type, the infectious
disease diagnostics market is segmented into COVID-19, HIV, HAIs, hepatitis,
CT/NG, HPV, TB, influenza, and other infectious diseases. In 2020, the COVID-19
disease type segment accounted for the largest share of this market. Factors
such as the increasing number of cases and the availability of many COVID-19
diagnostic tests are driving the growth of this market.
The diagnostic laboratories segment
accounted for the largest share of the infectious disease diagnostics market,
by end user segment, in 2020
Based on end user, the infectious disease
diagnostics market has been segmented into diagnostic laboratories, hospitals
& clinics, academic research institutes, and other end users. In 2020,
diagnostic laboratories accounted for the largest share of the infectious
disease diagnostics market. Diagnostic laboratories command the major share of the
infectious disease diagnostics market owing to increased test volume of
infectious diseases and strengthening healthcare infrastructure for efficient
disease diagnosis and treatment.
North America is the largest regional
market for infectious disease diagnostics market
The infectious disease diagnostics market
is segmented into five regions, namely, North America, Europe, Asia Pacific,
Latin America, and the Middle East & Africa. In 2020, North America
accounted for the largest share of the infectious disease diagnostics market.
The large share of this region can be attributed to the highly developed
healthcare system in the US and Canada, the presence of many leading national
clinical laboratories, and the easy accessibility to technologically advanced instruments.
he major players operating in this market
are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux
SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US),
Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany),
Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN
(Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad
Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics
(US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures
(Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio
Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc.
(US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron
Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios
International, Inc. (US), and ABACUS Diagnostica Oy (Finland).
Don’t miss out on business opportunities
in Infectious Disease Diagnostics Market. Speak to our analyst and gain crucial
industry insights that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B
research on 30,000 high growth niche opportunities/threats which will impact
70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers
worldwide including 80% of global Fortune 1000 companies as clients. Almost
75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators, strategic
players) annually in high growth emerging segments. MarketsandMarkets™ is
determined to benefit more than 10,000 companies this year for their revenue
planning and help them take their innovations/disruptions early to the market
by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive
intelligence and market research platform, "Knowledgestore" connects
over 200,000 markets and entire value chains for deeper understanding of the
unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com